Summary of clinical results
DUCRAY
Clinical study of the safety and efficacy of KELUAL DS Anti-Squamous Cleansing Gel in subjects with pityriasis versicolor.
Dermatologically-controlled clinical study of the safety and efficacy of KELUAL DS Anti-Squamous Cleansing Gel for face and body in adolescents and adults with mild to moderate pityriasis versicolor.
Population
30 subjects included with :
- At least 25% males.
- 10 adolescents (12 to 17 years)
- 20 adults (18 to 65 years)
with mild to moderate pytiriasis versicolor on the body
- Erythema ≥ 1
- Pruritus ≥ 1
- Desquamation ≥ 1
- Pigmentation ≥ 1
Application of KELUAL DS Anti-Squamous Cleansing Gel
1 single application per day
Evaluation criteria
- Clinical score by investigator: desquamation, erythema (scale from 0 to 4)
- Subject rating: average pruritus (analog scale from 0 to 10)
- Cutaneous and ocular tolerance
Results
Highly significant reduction in clinical signs after 7 days of treatment: desquamation, pruritus and erythema.
Intra-group analysis, **: p<0.001
Evolution of the clinical score after 21 days of application
Pityriasis versicolor
** p<0.001 vs Baseline
Conclusion
KELUAL DS Anti-Squamous Cleansing Gel improves desquamation and pruritus after 7 days of application, and all other factors such as pigmentation and erythema after 21 days.
Very good cutaneous and ocular tolerance.
More summaries of clinical results
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.